10-12 September 2018 //  Lancaster Royal Hotel, London

Interview with Stephane Boissel, CEO, TxCell

Developing Cellular immunotherapies using regulatory T cells to treat severe inflamatory & autoimmune diseases



2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad